Eupraxia Pharmaceuticals Inc (EPRX) — Capital Reinvestment Ratio

Latest as of March 2020: 0.01x

Eupraxia Pharmaceuticals Inc (EPRX) has a Capital Reinvestment Ratio of 0.01x as of March 2020, meaning it reinvests 0% of its operating cash flow (CA$503.92K) in capital expenditures (CA$3.80K). See EPRX equity to assets ratio to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.01x

Capex / Operating Cash Flow

Operating Cash Flow

CA$503.92K

CAD

Capital Expenditures

CA$3.80K

CAD

Data as of

Mar 2020

Most recent filing

Annual Capital Reinvestment Ratio for Eupraxia Pharmaceuticals Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Eupraxia Pharmaceuticals Inc from None to None. For live market cap and broader valuation context, see Eupraxia Pharmaceuticals Inc (EPRX) market capitalisation.

Year	Reinvestment Ratio	Operating CF (CAD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow